Futura Medical PLC (FAMDF)
0.40
-0.02
(-5.21%)
USD |
OTCM |
Apr 23, 11:01
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 120.58M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -47.25% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 30.53 |
| Price to Book Value | 17.28 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 93.06% |
Profile
| Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief. |
| URL | https://www.futuramedical.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Sep. 18, 2024 (est.) |
| Last Earnings Release | Apr. 10, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief. |
| URL | https://www.futuramedical.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Sep. 18, 2024 (est.) |
| Last Earnings Release | Apr. 10, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |